Abstract Body

Background: Immune responses to human cytomegalovirus (CMV) increase with age and HIV-infection and correlate with cardiovascular disease markers. We previously demonstrated greater odds of functional impairment among HIV-infected persons with higher CMV IgG concentrations, immune activation (%CD38HLA-DR on CD8+ T cells) and inflammation (IL-6, TNF-alpha). Here we evaluated the hypothesis that cell-mediated CMV responses were associated with functional impairment and inflammation/activation in persons aging with HIV infection. Methodology: Case-control study of 45-65 year-old HIV-infected subjects, on antiretroviral therapy >6 months, plasma HIV-1 RNA <48 c/mL. Low function (LF) cases and high function (HF) controls were identified by clinical criteria, and matched by age, gender, and time since HIV diagnosis. CMVspecific T cell responses were determined by the proportion of CD4+ and CD8+ T cells expressing IFN-ɣ after stimulation with CMV pp65 peptides and described using geometric mean and 95% confidence intervals (CI). Odds of LF was estimated by conditional logistic regression. Associations between continuous variables were described by Spearman correlation. Results: 30 LF cases were matched to 48 HF controls; mean (SE) age 53 } 0.8 years; 21% female; 76% Caucasian and 17% Hispanic. Compared to controls cases had similar current CD4 (549 } 49 vs 639 } 40 cells/μL, p=0.16), lower nadir CD4 (110 } 27 vs 178 } 22 cells/μL, p=0.04) and greater smoking prevalence (48% vs 20%, p=0.01). As previously reported, higher CMV IgG was associated with a 5-fold greater odds of LF (CI 1.5, 17.0) per log10 increase in CMV IgG (p=0.01) and was correlated with markers of inflammation: IL-6 (r=0.37, p<0.001), hs-CRP (r=0.29, p=0.01), TNF-alpha (r=0.24, 0.04); activation: %CD38+HLA-DR+ CD8+ T cells (r=0.21, p=0.07); and immune senescence: %CD28-CD8+ T cells (r=0.27, p=0.02). Odds of LF were not significantly different by CMV-specific CD8+ T cells (1.08; 0.92, 1.28; p=0.35) or CD4+ T cells (OR 0.99; CI 0.76, 1.29; p=0.95). Correlation was detected between CMV IgG and CMV-specific CD8+ T cells (r=0.30, p=0.007) but not CMV-specific CD4+ T cells (r=0.17, p=0.15). CMV-specific CD8+ T cells were not correlated with inflammation, activation, or senescence markers; all r≤|0.12|, p≥0.31. CMV-specific CD4+ T cells were correlated with CD28-CD4+ T cells (r=0.37, p<0.001), but not inflammation or activation markers; all r≤|0.11|, p≥0.36. Conclusions: Cell-mediated immune response to CMV was not a significant predictor of low physical function and was not associated with inflammation/activation among HIV-infected adults on effective ART. CMV-specific humoral responses are more strongly correlated with functional impairment and related inflammation, activation and senescence.